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INTRODUCTION
The prostate is a small organ situated deep in male pelvis and is the 
organ most prone to pathological change. Indeed, all men who live past the 
age  of  50  will  develop  histological  change  within  the  prostate,  most 
common process being BPH. Many older men also develop prostate cancer 
the second most common carcinoma in men.
For  a  long  time  using  conventional  imaging  techniques  we  were 
unable  to  directly  visualize  the  prostate.  However  we  assessed  the 
prostatic  enlargement  by  its  effect  over  adjacent  structures  like  prostatic  
urethra, bladder base and distal ureters by doing voiding cystourethrogram, 
cystogram and intravenous urogram. But we were not able to characterize 
various prostatic lesions.
Nowadays  with  the  advent  of  sectional  imaging  techniques  like 
ultrasound, computerised tomography and magnetic resonance imaging, we 
are  able  to  directly  visualize  the  prostate.  Since  ultrasound  is  free  from 
radiation  hazards  and  because  of  its  easy  availability,  it  is  a  valuable 
technique for detecting prostatic diseases.
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With  the  advent  of  Transrectal  sonography  we  are  able  to  get  a 
detailed view of prostate. As we are using high resolution transducers with 
high  frequency  ranges  and  sharply  focused  near  fields,  we  are  able  to 
appreciate  zonal  anatomy  of  prostate,  the  lesion  distribution  and  to 
characterize various prostatic lesions.
Colour  Doppler  techniques  help  us  to  know the  vascular  nature  of 
various lesions and thus help to differentiate and localise the lesions.
Magnetic resonance imaging helps us to get multiplanar views of the 
prostate  along  with  adjacent  structures  in  the  pelvis.  Also  it  is  able  to 
clearly delineate the zonal anatomy especially with Endorectal coil.
With  Transrectal  sonography  we  are  able  to  localise  the  lesions 
accurately and under its guidance, biopsies are taken. 
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AIMS AND OBJECTIVES
• To  categorize  prostatic  diseases  as  benign  and  malignant 
depending on their sonographic appearances.
• To  assess  the  role  of  colour  Doppler  in  localizing  and 
differentiating prostatic lesions. 
• To evaluate  various  prostatic  lesions  depending  on  their  MR 
signal characteristics.
• To  do  TRUS  guided  biopsy  of  suspicious  lesions  and  to 
confirm by histopathology.
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HISTORY AND REVIEW OF LITERATURE
Wild and Reid first proposed a screw type trans-rectal scanner in the 
early  days.  The  principle  was  identical  to  that  of  modern  transrectal  
ultrasonography although the investigators obtained only a square picture, 
presumably  thought  to  represent  a  part  of  the  rectum.  In  the  following 
decades,  trials  with  transrectal  scanner  of  the  A  –  mode  type  were 
reported, but this mode of presentation was not successful because of the 
difficulties in interpretation.
Watanabe1 and associates turned the concept to more practical use, 
with  modern electronic techniques and established the basic standard for 
imaging of the prostate. Their original scanner used a single oscillating disk 
and  had  both  radial  and  linear  scanning  functions.  King  and  associates 
introduced the method in the United States in 1973 and were followed by 
Resnick and  co-workers.  
Hallemans  and  Squassabia  et  al reported  European  results  with 
transrectal sonography at the same time.
In  1980  Harado  et  al applied  grey  scale  imaging  to  transrectal 
ultrasound.  Itakura  et  al developed  a  pistol  type  hand  held  transrectal 
scanner. Recent advancement of electronic real time ultrasound has made 
it possible to set many small oscillating discs in a thin probe for transrectal 
use. Sekine et al reported the first trial with this probe in 1982 . Riffkin and 
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Lee et al soon reported its use in United States. Now a days scanner with 
dual transducers called biplanar transducers are available.
Saitoh  et  al in  1981  developed  a  special  unit  for  interventional 
ultrasound  consisting  of  a  transrectal  electronic  linear  scanner  and  an 
attachment  for  needle  guidance for  the  puncture  of  prostate  and seminal  
vesicle.  
Holm and Gammelgaard et al in the same year  developed a system for 
precise  needle  placement  used  along  with  trans-axial  ultrasound 
monitoring.
Watanabe  et  al1 proposed  diagnostic  criteria  for  various  prostatic 
lesions by transrectal sonography which were later approved as the official  
criteria  of  the  Japan  Society  of  Ultrasonics  in  medicine  and  Japanese 
Urological Association.
In  1985  Lee et  al22 established the  hypoechoic lesion as a  sign of 
cancer  focus and this  finding  had a  great  impact  on  the  advancement  of 
early cancer detection by transrectal ultrasonography.
Ohe et al proposed a factor called presumed circle area ratio (PCAR) 
that relates to the degree of roundness of prostate in axial  section which 
has close relation with benign hyperplasia.
Griffifths  et  al addressed  the  ultrasound  features  of  chronic 
prostatitis.  
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In 1981 Holm and Gammelgaard et al first described transperineal biopsy 
by  transverse  ultrasound  guidance.  In  1983  Fornage  and  Rifldn  et  al. 
described  a  technique  using  longitudinal  ultrasound  guidance  for 
transperineal biopsy of prostate. Combination of transverse and longitudinal 
imaging  for  guiding  transperineal  biopsy  was  described  by  Lee  et  al in 
1987.  In  1986  the  development  of  biplanar  transducers  made  biopsy  via  
transrectal route possible.
MRI  of  the prostate has evolved along with  developments  in  Radio 
frequency coils and in MR pulse sequences. Initially only body coil MR with 
conventional spino-echo pulse sequences were used.
Endorectal  surface  coil  was  first  developed  in  1988.  The  use  of 
endorectal  surface  coil  increases  signal-to-noise  ratio  at  the  expense  of 
small  field  of  view.  To  compensate  this  recently,  Integrated  Endorectal  
External Phased array coil  is used which allows more homogenous signal 
over a larger field of view.
With  the  advent  of  colour  Doppler  techniques,  it  was  also  used  in 
prostatic  lesion  where  it  helps  to  reinforce the  suspicious lesions with  its 
hypervascularity and helps to guide for biopsy.
NORMAL ANATOMY AND REVIEW OF PATHOLOGY
The  prostate  gland  is  a  flattened,  conical  structure  oriented  in  a 
coronal  plane. Its  apex points downwards and is located just above deep 
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fascia of the urogenital diaphragm. Its anterior surface is directed towards  
the  symphysis  from  which  it  is  separated  by  adipose  tissue  and 
periprostatic veins. The anterior fibromuscular band separates the prostate 
proper from the preprostatic space, and the posterior surface is separated 
from the rectum by a double layer of Denonviller’s fascia. The length of the  
normal prostate is 2.5 to 3.0 cm; the transverse diameter at the base is 4.0 
to  4.5  cm;  and  the  thickness  is  2.0  to  2.5  cm.  The  dimensions  often 
increase  with  age,  and  the  normal  weight  of  20  to  25gms;  may  be 
surpassed  several  times.   The  prostate  is  surrounded  by  a  capsule, 
approximately  10mm in diameter  consisting of  fibromuscular  strands from 
which the puboprostatic ligament extends.
Mc  Neal  in  1968  introduced  a  zonal  concept  of  prostate  anatomy, 
defining  3  glandular  zones -  Transition,  Central,  and  Peripheral  — which 
are covered anteriorly by fibromuscular stroma. The urethra and ejaculatory 
ducts form the framework for the glandular zones. Each zone has a unique 
spectrum of clinical disease because of its internal anatomic features.
CENTRAL ZONE:
The  central  zone  is  triangular  and  constitutes  the  major  mass  of 
glandular  tissue  at  the  base  of  the  prostate.  Its  apex  is  at  the 
verumontanum. Approximately 25% of prostatic glandular tissue originates 
from this zone. Ducts in the central zone radiate from the base of the gland 
and terminate in the urethra at the proximal aspect of the verumontanum. 
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Ducts of the vas deferens and seminal vesicles form the ejaculatory ducts 
which  pass  through  the  central  zone  and  empty  in  to  the  urethra  at  the 
verumontanum. Disease processes rarely affect the central zone, and it is  
the site of origin of only 5 to 10% of prostate cancers.
The site  where  the  seminal  vesicle  and the ejaculatory ducts enter 
the central zone is devoid of prostate capsule. The seminal vesicles join the 
vas deferens at the base of the prostate to form the ejaculatory ducts. The 
extra  prostatic  space  invaginates  around  the  ejaculatory  ducts  and 
continues to  the  verumontanum as the invaginated extra  prostatic  space. 
Thus a path in the centre of the gland connects the extraprostatic space at 
the  base  with  the  apical  portion  of  the  gland  at  the  verumontanum.  On 
sagittal  projection,  this  is  seen  as  a  hypoechoic  beak  like  configuration 
formed  by  the  entrance  of  the  seminal  vesicle  and  vasdeferens  into  the 
central  zone.  This  beak  continues  as  a  hypoechoic  band  formed  by  the 
smooth  muscle  surrounding  the  ejaculatory  ducts  and  extends  to  the 
verumontanum.
Hypoechoic  tumour  invading  the  central  zone  has  ready  access  to 
the  invaginated  extraprostatic  space.  Obliteration  or  displacement  of  the 
beak of seminal vesicles may indicate extracapsular extension of tumour. If  
invasion of  the invaginated extra  prostatic  space is  the earliest  finding of 
seminal vesicle involvement, the ultrasound criteria are then, 
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1. A  hypoechoic  halo  or  ring  like  mass  about  the 
ejaculatory duct on the axial section.
2. Obliteration or  displacement of  beak of  seminal  vesicle 
by hypoechoic cancer seen on sagittal scan. 
3. Hypoechoic cancer extending into the seminal vesicle  
4. An extra  prostatic  hypoechoic  mass  at  the  entrance  of 
the seminal vesicle obliterating the seminal vesicle — prostate 
angle.
PERIPHERAL ZONE
The  peripheral  zone  contains  approximately  70%  of  the  glandular 
tissue  in  the  normal  prostate.  Its  glands  are  uniform  in  size  and  smaller 
than  that  of  central  zone.  The  peripheral  zone  occupies  the  posterior, 
lateral  and  apical  regions  of  the  prostate  and  extends  anteriorly  for  a  
variable  distance.  The  ducts  enter  the  urethra  at  a  point  distal  to  the 
verumontanum. The zone is homogenous in echo texture and is defined as 
isoechoic.
Approximately  70%  of  prostate  cancers  originate  in  the  peripheral 
zone.  The  majority  of  these  cancers  are  located  close  to,  or  in  direct 
contact  with  the prostate  capsule.  Cancer  spreads along the subcapsular 
space or the interstitial space between the prostatic acini and the ducts of  
the peripheral zone. The inward spread of cancer is resisted by the surgical 
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capsule, a muscular interface between the peripheral  and transition zone. 
Cancer of the peripheral zone readily invades the central zone, giving them 
access to the invaginated extraprostatic space.
The prostatic capsule is thin or absent at the apex of the gland. The 
region  distal  to  the  apex,  bounded  by  the  peripheral  zone  proximally,  
rectourethralis muscle distally, the membranous urethra anteriorly, and the  
rectal  wall  posteriorly  is  designated as the  Trapezoid  area.  Tumour may 
readily spread from the peripheral zone into the trapezoid area, which may 
be considered as a region of anatomic weakness.
TRANSITION ZONE:
The  transition  zone  approximately  forms  5%  of  the  prostatic 
glandular  tissue.  In  aging  prostate  this  zone  can  show marked  glandular  
hyperplasia  and  eventually  may  constitute  the  majority  of  the  prostatic 
glandular volume.
The transition zone is located on both sides of the proximal urethra. 
The ducts run parallel to and end in the proximal urethra at the level of the  
verumontanum. Prostatic  calculi  within  the glands of  the proximal  urethra 
and  verumontanum  produce  an  Eiffel  Tower  -  shaped  hyperechoic 
configuration  that  defines  the  distal  limits  of  the  transition  and  central 
zones.  The  surgical  capsule  separates  the  transition  zone  from  the 
peripheral and central zones.
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The  understanding  of  the  gross  and  microscopic  anatomy  of  the 
prostate  has  changed  during  the  past  few  decades.  The  classic 
understanding of prostate anatomy was the division of  the gland into five 
lobes, termed Lowsley’s lobar concept of anatomy. This method has been 
used  to  identify  the  prostatic  disease  for  close  to  100  years.  However,  
Lowsley’s  concept  of  anatomy  did  not  consider  the  different  histological  
components of the prostate but was based purely on anatomic position as 
defined in the embryonic and foetal gland. In this description, the prostate 
was  divided  into  five  major  lobes.  The  first,  the  anterior  lobe  is  in  the 
anterior portion of the prostate. It is situated from the anterior margin of the 
gland to the level of the prostatic urethra posteriorly. The middle or median 
lobe  is  a  smaller  area  between  the  proximal  prostatic  urethra  and  the 
ejaculatory  ducts.  This  lobe  extended  from  the  base  to  the  level  of  the 
verumontanum  in  the  midportion  of  the  prostate  The  posterior  lobe 
encompassed  the  posterior  portion  of  the  prostate  and  was  situated 
posterior  to  the  ejaculatory  ducts  and  the  prostatic  urethra  The  posterior  
lobe  extended  to  the  posterior  margins  of  the  gland  The  fourth  and  fifth  
lobes were the two large lateral lobes that extended from the lateral margin 
of the prostate bilaterally towards the middle part of the gland. None of the 
lobes had clearly defined medial margins.
The comparison of the Lowsley lobar and McNeal zonal concepts of 
the  anatomy  is  both  possible  and  important  because  of  the  need  to  
compare  clinical  findings  and  the  terminology  with  imaging  studies.  The 
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anterior lobe correlates with the anterior fibromuscular stroma. The median  
lobe and central zone are similar. The sum of the posterior and two lateral  
lobes correlates to the large peripheral zone.
Initially,  McNeal’s  concept  of  zonal  anatomy had  little  utility  in  the 
clinical sphere or in diagnostic imaging. However with the development of 
cross- sectional imaging studies, endorectal sonography and MR imaging, 
the  zonal  concepts  of  anatomy  became  a  useful  technique  to  apply  to  
imaging because the different areas can be defined. Both sonography and 
MR  imaging  can  differentiate  the  normal  central  gland  from  a  peripheral 
gland.  In  the  hyperplastic  prostate  they  differentiate  benign  hyperplastic  
areas from normal tissues.
The zonal concept of anatomy is also useful because it incorporated 
a  clearer  understanding  of  the  development  of  disease.  The  origin  of 
prostatic disease within the gland was poorly understood under Lowsley’s  
concepts  of  lobar  anatomy.  It  was  previously  thought  that  cancers  only 
arise  in  the  posterior  lobe and the  benign prostatic  hyperplasia  develops 
predominantly  in  the  lateral  and  to  a  lesser  degree in  the  median lobes. 
These concepts were based on the clinical presentation of disease, not on 
actual  position of the tumours and were inaccurate. The concept of  zonal 
anatomy has clarified much of this misunderstanding.
It  is  now  understood  that  prostate  cancer  develops  in  the  acinar 
tissue, predominantly the peripheral prostate.  The peripheral zone is three 
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times  larger  in  volume than  the  central  zone.   Prostate  cancer  develops 
seven times more often in  the peripheral  zone.  Approximately  70% of  all  
cancers develop in the peripheral zone 20% from transition zone and 10% 
from  the  central  zone.  In  contrast  benign  prostatic  hyperplasia  develops 
exclusively  from  transition  zone.  Prostatitis  develops  predominantly  from 
the peripheral zone.
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McNEAL’S  ZONAL ANATOMY OF PROSTATE
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SONOGRAPHIC FEATURES OF NORMAL PROSTATE
On TRUS obtained in the transverse plane of Imaging the prostate is 
visualized as a symmetrical crescent-shaped ovoid structure with triangular 
posterolateral  margins.  Zonal  anatomy  is  routinely  seen.  The  peripheral  
zone is imaged with homogenous medium echogenicity. The transition zone 
is  imaged  with  lower  echogenicity  and  often  has  an  inhomogenous  echo 
pattern.  Dense  echogenic  foci  at  the  margin  between  the  peripheral  and 
transition  zone  can  be  seen  and  these  represent  corpora  amylacea. 
Anteriorly  echogenic  rim represents  the  anterior  fibromuscular  band.  The 
capsule is not directly visualized, but lies at the junction of the peripheral 
zone and the periprostatic fat. The seminal vesicles may be seen in a bow-
tie configuration on a transaxial view.
TRUS  in  the  sagittal  projection  is  useful  for  evaluating  the 
craniocaudal  margins  of  the  prostate  &  volumetric  measurements  of  the 
prostate.  Using a combination of sagittal  and transverse plane allows the 
calculation of prostatic size using the ellipsoid formula
V = ½ (L x AP x W)  
L - Length
AP - Antero posterior diameter
W - Width
20
Normal MRI Anatomy:
On MRI the ability to demonstrate the zonal anatomy of the prostate 
gland and the distinction between the gland and periprostatic tissues varies 
with  the  imaging  planes  and  sequences  used.  On  T 2 -  WI,  the  zonal 
anatomy is  well  delineated.  With  the prostatic  urethra  serving  as the  key 
reference point on T2WI, the PZ demonstrates higher signal intensity than 
either the central or the transition zones. 
The central  and transition zones have similar  lower  signal  intensity 
and can be differentiated from each other by knowledge of their anatomical  
location.  In  young  subjects,  the  transition  zone  has  uniformly  low  signal  
intensity but  it  becomes heterogenous with  the development of  BPH. The 
surgical  pseudocapsule  can  be  seen  in  older  subjects  at  the  interface 
between  the  transition  and  peripheral  zones.  The  anterior  fibromuscular 
band covering the anterolateral surface of the prostate gland demonstrates 
a  low  signal  intensity  allowing  distinction  between  the  prostate  and  the 
anterior periprostatic space composed of vascular areolar tissue.
On axial T2-WI the shape of the peripheral zone changes from base 
to  apex.  The apical  urethra  is  surrounded  by  muscular  fibres  giving  low-
intensity signals.
The  NVB  are  seen as  punctuate  signal  voids,  posterolateral  to  the 
capsule at the 5 and 7 O’ clock position. The levator Ani muscles give lower  
signal intensity than the peripheral zone, regardless of which spin-echo TR 
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or  TE is  used,  though the  contrast  between  the  peripheral  zone and  the 
levator  Ani  muscles  is  enhanced  on  T2-WI.  Unlike  CT,  MR  in  all  three 
planes enables the prostate to be differentiated from surrounding levator, 
bladder  neck  &  lower  rectum.  In  the  assessment   prostate  size  using 
Ellipsoid formula, MR is more accurate than USG or   CT.
Colour  Doppler  evaluation  of  the  prostate  has  shown  that  most 
cancers  are  hyper  vascular.  The  cancers  there  are  hypoechoic  in  grey 
scale are hyper vascular when evaluated with the colour Doppler technique 
spectral  analysis  has  demonstrated  that  the  vessels  within  the  prostate 
have a resistive index between 0.50 and 0.80 and velocities between 9 and 
30cm/s. These valves are not changed within a cancer as prostatitis. The 
infiltrating cancers are 180 vascular  as cell  as being isoechoic.  Both A/C 
and C/C prostatitis  and occasionally  atrophy demonstrate  increased flow. 
The  use  of  the  power  Doppler  technique  has  not  offered  any  additional 
information when compared to conventional colour Doppler sonography.
BENIGN PROSTATIC HYPERPLASLA
Benign  prostatic  hypertrophy  is  an  age  related  disorder  found  in 
majority  of  men  by  the  sixth  decade.  It  mainly  involves  periurethral  
transition zone. As the transition zone enlarges it causes compression and 
distortion  of  prostatic  urethra  and  outward  displacement  of  the  normal 
prostatic  tissue  which  becomes compressed as  a  narrow layer  forming  a 
false capsule.
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Histologically several cell types are concerned with the development 
of  BPH including  glandular  epithelial  cells,  fibroblasts,  myoepithelial  cells  
and  smooth  muscle  fibres.  The  aetiology  of  BPH  is  uncertain.  But  the 
prostate  develops  and  become  hyperplastic  only  in  men  with  normal 
androgen  production.  The  principle  prostatic  androgen  is  Dihydro-
testosterone, an alpha reduced metabolite of testosterone. Serum levels of 
17-oestrodiol increases with age and increase the oestradiol /testosterone 
ratio  which  may be relevant  to  the  development  of  BPH Prostate  stroma 
contains high level of oestrogen receptors and 17-oestrodiol enhances the 
androgen receptor content of the prostate.
Prostatic obstruction increases the resistance to the flow of urine and 
the detrusor  muscle responds by hypertrophy.  The bladder  wall  becomes 
thickened  and  trabeculation  occurs  with  intervening  sacculation  and 
diverticula  formation.  The  bladder  capacity  increases  and  back  pressure 
may be transmitted to the upper tract causing obstructive uropathy. Urinary 
stasis  due  to  residual  urine  predisposes  to  infection  and  bladder  stone 
formation.  The  chronically  distended  bladder  may  decompensate  and 
chronic retention and overflow incontinence ensues.
Clinically  patient  may  present  with  obstructive  symptoms  like 
hesitancy,  poor stream and acute retention of urine or irritating symptoms 
like urgency, urge incontinence, precipitancy and nocturia.
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Sonographically  prostate will  assume a more rounded configuration 
due  to  increased  AP  dimension.  Transition  zone  will  be  hypertrophied 
causing  compression  of  rest  of  the  glandular  tissue  causing  good 
demarcation of surgical capsule. There may be calcareous deposition along 
the  surgical  capsule  or  along  the  transition  zone  glandular  ducts  which 
gives  a  specific  configuration  called  EIFFEL  TOWER  appearance.  The 
gland  may  be  either  homogenous  or  inhomogenous  in  echo  texture 
depending  on  whether  it  is  fibromuscular  stromal  proliferation  or  mixed 
fibrous and glandular element proliferation. Pure adenomatous hyperplasia 
will be seen as hyperechoic nodules.
As benign prostatic hyperplasia develops from the transition zone the 
rest  of  the  glandular  zone  is  compressed.  This  results  in  marked 
sonographic  difference  between  central  and  peripheral  portion  of  the 
prostate.  BPH is generally defined as well  demarcated, well  differentiated 
enlargement of  the central  gland (transition zone).  A single relatively well  
demarcated focus may be identified or multiple benign hyperplastic nodules 
may  be  noted.  The  area  separating  the  hyperplastic  tissue  from  the 
compressed  peripheral  zone  is  the  ‘surgical  capsule’.  This  region  the 
surgical  capsule  may  be  demarcated  by  a  well  defined  change  in 
echogenicity, a hypoechoic rim or calcifications.
BPH can be demonstrated by MR, though it cannot be differentiated 
from prostatic carcinoma. Its  appearance varies depending on the type of  
hypertrophy and the imaging protocol used. In nodular hyperplasia enlarged 
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prostate gland with homogenous signal intensity with nodules of diminished 
intensity on T1 - WI and varying intensity on T2-WI is seen.
A  surgical  pseudocapsule  imaged  with  low  signal  intensity  can  be 
seen  at  the  margin  between  Adenoma  and  the  PZ.  Diffuse  hyperplasia 
ranges in  appearance from or  homogenous or  inhomogenous,  medium to 
high signal  intensities on T2-WI.  The ability  of  MRI  to  provide multiplanar 
imaging  allows  accurate  volumetric  measurement  of  the  hypertrophied 
gland and displays  the intravesical  portion of  the hyperplastic nodule and 
demonstrates the effect of hypertrophy on the bladder neck.
PROSTATIC CANCER
Cancer prostate is the second most common cause of cancer death 
in men in the United Kingdom and USA. The incidence is more than 30% in 
men aged over  50 years  and as high as 80% at  the age of  80 years.  At 
initial diagnosis approximately 75% will have either locally invasive disease 
or distant metastasis, 5 year survival rate is 15%.
There  are  no  known  causal  etiological  factors.  There  is  a  genetic 
predisposition  as  the  risk  is  two  to  three  times  greater  in  first  degree 
relatives of prostate cancer patients.
Approximately  70%  of  prostate  carcinomas  arise  in  the  peripheral 
zone,  25°% in  the transition zone and the remainder  in the central  zone. 
Prostate cancer spreads locally by direct invasion through the capsule, to 
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the seminal  vesicles through the invaginated part  of  extraprostatic  tissue. 
Lymphatic spread to obturator and internal iliac nodes and then to common 
iliac  and  para  aortic  nodes.  Bones  are  usually  involved  through  blood 
spread (BATSONS VENOUS PLEXES) and the bones affected are lumbo-
sacral spine and pelvis.
Prostate Specific Antigen is an enzyme specific for prostatic tissue. It  
ha  largely  replaced  acid  phosphatase  as  marker  of  prostate  cancer.  The 
normal  reference  range  is  0-4  ng  /  ml.  A  value  greater  than  10ng/ml  is 
suspicious  of  cancer  while  a  value  above  40  ng  /  ml  suggests  extra 
capsular disease, and value of 100 ng / ml suggests distant metastasis.
Prostatic  cancer  classically  presents  in  the  peripheral  zone  as  a 
relative  poorly  marginated  hypoechoic  area.  These  lesions  are  often 
obvious  on  the  sonograpic  examination  because  of  the  considerable 
differences in echogenicity between tumour & normal appearing glandular 
tissue.  However,  not  all  large  lesions  have  this  typical  sonographic 
appearance.  Studies  have  shown  that  up  to  40% of  tumours  lesser  than 
5mm in size when evaluated by radical  prostatectomy specimens,  cannot 
be identified by endorectal sonogram. These are not seen directly because 
they  are  of  the  same echogenicity  as  the  remainder  of  the  prostate,  but 
some may still be identified by their secondary characteristics like capsular 
bulge or erosion. Capsular bulge is not a specific sign of tumour infiltration,  
although irregularity of  the pericapsular fat  is highly suggestive of tumour  
infiltration.  Lesions  with  mixed  echogenic  appearances  with  subtle 
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scattered  areas  of  decreased  echogenicity  also  may  be  identified  The 
reasons for these differences in echogenic appearances of prostate cancer 
are 
1. Gleason  grade  of  the  tumour  (an  index  of  cellular 
differentiation)
2. Fibrotic change
3. Intermixing of benign prostatic tissue with cancer,
4. Increased number of interfaces,
5. Tumour size and 
6. Undefined causes. 
Tumour spreading through invaginated part  of extra  prostatic tissue 
will  obscure  the  normal  beaking  of  seminal  vesicle  at  its  entrance to  the 
prostate as ejaculatory duct.
The most common presentation of prostatic carcinoma in MR is the 
e/o hypointense signal lesion in the peripheral zone, regardless of the field 
strength  .However,  the  signal  intensity  changes  are  non  specific  and 
various benign and malignant condition can mimic each other. Differential 
considerations  for  low  signal  intensity  within  the  PZ  on  T 2 WI  include 
Tumour,  post  biopsy  haemorrhage,  post  radiation  and  hormone  therapy,  
scar / positional inflammatory changes, and dystrophic changes.
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The major role of MRI in prostate carcinoma is in the local staging of  
the  disease  each  parameter  of  tumour  extension  of  capsular,  seminal 
vesicular  and  bladder  involvement  can  be  assessed  separately. 
Extracapsular entension of tumour usually begins posterolaterally adjacent 
to  the  NVB  (at  the  5&7  ‘O’  clock  positions)  where  the  nerve  branches 
perforate the capsule. The criteria used for the detection of extra capsular 
extension of tumour on T2-WI include  
1. Broad (>12mm) tumour contact.
2. Smooth capsular bulge. 
3. Irregular capsular bulge.
4. Obliteration of the rectoprostatic angle.
5. Asymmetry or direct involvement of the NVB.
6. Angulation or step- off appearance.
7. Focal capsular retraction and thickening.
According  to  YU et  al28 obliteration  of  the  rectoprostatic  angle  and 
asymmetry  of  the  NVB  were  most  indicative  of  extracapsular  extension. 
Criteria used for the defection of seminal vesicular invasion include.
1. Direct tumour extension into & around the seminal vesicles.
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2. Tumour  extension  along  the  ejaculatory  ducts,  resulting  in 
seminal  vesicles  of  low  signal  intensity  on  T2  WI  &  Non 
Visualization of ejaculatory duct.
The  detection  of  prostate  cancer  and  the  accuracy  in  staging  is 
improved when MRI is used in conjunction with  3D- MRSI. Higher choline 
and lower citrate levels are seen in prostatic tissue containing cancer than 
in normal prostatic tissue. 
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PROSTATE CANCER STAGING
WJ TNM DEFINITIONS AJC OSC
A T0 Non  palpable  tumour;  incidental  finding  in 
operative  specimen
T1 TA
A1 Toa <3hpf  
<5% of specimen
T1a 
T1b
TA1 
TA2
B T1 Palpable tumour confined to the gland T2 TB
B1 T1a Confined to one lobe <2cm T2a TB1
B2 T1b Confined to one lobe> 2 cm T2b TB2
B3 T2 Both  lobes  involved.  Contour  deformity  of  the 
gland No seminal vesicle involvement.
T3a TC1
C1 T3 Both  lobes  involved  contour  deformity  and 
seminal vesicle involvement.
T3b TC2
C2 T4 Contour deformity, seminal vesicle involvement 
and invasion of adjacent pelvic organs
T4 TC2
D N1-3 Secondary involvement of regional lymph node 
only
N+ M1 
N1-2
D1 N4 Metastasis to juxtaregional nodes N3
D2 M1 Distant metastasis M1 M2
WJ-   Whitmore -Jewett
TNM-   Tumour, Node, Metastasis.
OSCC - Organ Site Programe of National Cancer Institute. 
AJC-     American joint committee
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CLINICAL STAGING SYSTEM FOR PROSTATE CANCER
A1 Non-palpable, incidentally found cancer in <5% of prostatic 
specimen.(TURP)
A2 Tumour cells found in >5% of prostatic specimen.
B1 Palpable nodule <1.5cm confined to one lobe.
B2 Both lobes involved.
C1 Extension  into  lateral  sulci  or  seminal  vesicles  <6cm  in 
maximum diameter.
C2 >6cm  or  fixed  to  pelvic  side  walls  or  invading  adjacent 
organs
STRUCTURES  OTHER  THAN  MALIGNANCY  THAT  PRODUCE  
HYPOECHOIC AREAS IN THE PROSTATE                                          
A)      ANATOMIC STRUCTURES
Urethra and periurethral fibromuscular tissue.
Ejaculatory duct complex.
Prostate capsule. 
Seminal vesicles ampulla of vas deferens.
Periprostatic veins.
Neurovascular bundle.
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B)      BENIGN DISEASES
Hyperplasia
Granulomatous and nonspecific prostatitis.
Cysts.
Haematoma
C)       ARTIFACTS
Inappropriate use of focal range of transducers.
Acoustic shadowing.
Edge effect.
Reverberation artefact.
Edge effect is seen when the angle of incidence of the sound waves 
on  a  tissue  plane  leads  to  rarefaction  rather  than  reflection.  The  sound 
wave is deflected, and the returned echoes are interpreted as being from a  
more lateral  position .As a result a fan shaped anechoic area is seen. An 
edge effect is most commonly seen on transverse scanning of the base of  
prostate  at  the  lateral  margins  of  the  transition  zone.  The  result  is  a  
hypoechoic area in the anterior horn of the peripheral zone. A similar effect  
is often seen at the extreme edge of the prostate in the sagittal plane giving 
a ragged appearance to the lateral boundary.
Reverberations may be seen as bright white lines at regular intervals 
from the transducer.  They are caused by sound waves reflecting from an 
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echodense  surface  and  then  bouncing  between  the  transducer  and  the 
reflecting surface. The most common sites of reverberation echoes are at 
the surface of balloon surrounding the transducer in the rectum and faecal 
material  within  the  rectal  wall.  An  apparent  decrease  in  echo  density 
between  the  reverberations  may  make  the  prostate  seem  relatively 
hypoechoic.
PROSTATITIS
Prostatitis when due to haematogenous spread of infection involves 
the peripheral gland. When due to post-surgical instrumentation the central 
gland  may  be  affected.  Actually  there  are  no  specific  features  on 
sonography  unless  an  abscess  develops,  in  which  case  an  anechoic  to  
hypoechoic  area with  a  thin  or  thick  wall  may be seen.  The sonographic 
findings arc not diagnostic but in conjunction with clinical findings are highly 
suggestive of diagnosis.
On  MR,  Both  A/c  &  C/c  prostatitis  may  show multiple  small  areas 
increased  signal  intensity  scattered  throughout  the  prostate  on  SE-T 2W 
images.  Conversely c/c  prostatitis  /  scarring may cause decreased signal 
intensity  change  on  T2  WI  image  and  therefore  mimic  tumour.  When  a 
prostatic  abscess  develops,  discrete  rounded  foci  are  seen.  These  are 
hypointense on T1-WI and hyperintense on T2W - Images.
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PROSTATIC CYSTS
Prostatic utricle cyst 
Prostatic utricle cysts develop from utricle which is a normal structure seen 
as a dimple on the surface of the verumontanum. In 10% of individual 
utricle becomes larger and forms a slit like aperture lying between the 
ejaculatory ducts and extending in cephalad direction for a variable 
distance. The seminal vesicle and vas deferens do not communicate with 
dilated utricle. However a tense utricular cyst may obstruct the nearby 
ejaculatory ducts.
 Mullerian Duct Remnant Cyst
They  are  derived  from  remnants  of  paranephric  ducts.  They  are 
situated  more  caudally  than  the  normal  utricle.  Both  utricle  cyst  and 
mullerian duct remnant cyst are midline cysts.
Ejaculatory Duct Cyst
Cystic dilatation of the ejaculatory duct may occur either primarily or 
as a result of obstruction.
Degenerative Cyst of Prostate
Degenerative  cyst  within  the transition  zone and are  well  known to 
the urologist performing transurethral resection of prostate when such cyst 
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are often resected and jelly like material  is  released.  They are smaller in  
size.
Sonographic Features
A small cystic structure identified in the midline near verumontanum 
is  most  likely  to  be  utricle  cyst.  Mullerian  duct  cyst  tends  to  be  found 
towards the top of the prostate in midline. Cysts that are seen in the line of  
ejaculatory duct are ejaculatory duct cysts. They are often associated with  
azoospermia.
The seminal vesicles are seen as flat paired structures lying behind 
the bladder. The outline is usually smooth, although the saccular nature of 
the  gland  can  sometimes  be  appreciated.  The  centre  of  the  gland  is 
echopenic with areas of increased echo density corresponding to the folds 
of the excretory epithelium. If the seminal vesicle is distended, the wall can 
be seen to be composed of two thin layers.  Caudally the vesicle spreads 
laterally and can be seen ramifying in the perivesicular fat. 
The vasdeferens on either side can usually be identified behind the 
bladder  as  it  runs  inward  and  posteriorly  to  become  the  ampulla.  The 
cranial ampullary part of the vas may be seen as a separate structure, but 
in its more distal part, near to the prostate, it cannot be distinguished from 
the seminal vesicles. In the sagittal plane, the body of the seminal vesicles 
are  easily  appreciated.  The  junction  of  the  seminal  vesicle  with  the 
ejaculatory  duct  usually  lies  within  the  prostate.  Ultrasonography  of  the 
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intraprostatic portion of the seminal vesicle produces the ‘Beak sign’. The 
ejaculatory  duct  complex  from  each  side  lies  in  a  common  muscular  
envelope,  which  is  clearly  seen  by  sonography.  The  actual  lumen of  the 
ejaculatory ducts is  not  normally visible.  The path of  the ejaculatory duct  
can  be  traced  to  an  area  of  slightly  increased  echo  density,  which 
corresponds to the verumontanum. Small echo densities are often identified 
at the junction of the ejaculatory ducts and the urethra and provide a useful 
landmark.
SEMINAL VESICLE CYSTS
Seminal  vesicle  cysts  are  almost  associated  with  either  an  ectopic 
ureter  draining  into  seminal  vesicle  from a  dysplastic  kidney or  unilateral  
agenesis.  The diagnosis  is usually made at  the time of  increasing sexual 
activity when accumulation of material within the cysts leads to infection or 
obstruction of the ejaculatory ducts and consequent infertility. Cysts can be 
easily  identified  by  trans-rectal  sonography  as  an  echo  free  area. 
Configuration of contralateral seminal vesicle can be studied.
Owing to its excellent display of anatomy multiplanar MRI is useful in 
demonstrating the size and location of prostatic cysts. The signals intensity  
of the cyst depends on their fluid content. Serous fluid similar to urine will  
have a low signal intensity on SE T -1 WI and an increased signal intensity  
on  either  T1 or  
T2 - W Image.
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MATERIALS AND METHODS
A  prospective  study  of  50  patients  between  the  age  group  41-78 
years  admitted  in  Urology  Department,  Govt.  General  Hospital,  Chennai 
between July 2004 - August 2005, with prostatic complaints like hesitancy,  
poor  stream,
A/c retention of urine, urgency,  urge incontinence and nocturia was done. 
All 50 patients were subjected to Transrectal sonography (TRUS), MRI and 
TRUS guided biopsy.  TRUS  was performed using ALOKA -3500 equipped 
with  7.5  MHz  Transrectal  probe  ,  MRI  was  done  using  SIEMENS  1.5T 
superconducting magnetom, using CP spine array coil, colour Doppler was 
also used in evaluating the lesions.
Technique of TRUS:
Prior to TRUS we did Trans abdominal usg for every patient to assess the 
prostatic size.
1. All our patients are given a thorough cleansing enema.
2. They were put in left lateral decubitus position.
3. Thorough  inspection  of  the  anal  verge  was  done  to  rule  out 
any painful fissures.
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4. Digital  rectal  examination of the prostate was done for all  our 
patients  before  transrectal  sonography  which  will  help  us  to 
know where exactly to concentrate while doing sonography.
5. Good lubrication in the form of xylocaine jelly 2% applied.
6. By  asking  the  patient  to  take  deep  breath  the  trans-rectal 
probe was gently inserted into the rectum.
7. The probe we used was 7.5 MHz. Biplanar trans-rectal  probe 
which was having end firing and side firing crystals.
8. The  probe  was  inserted  till  we  reached  the  seminal  vesicles 
and we  examined the  prostate  in  various axial  sections from 
base to apex by slowly withdrawing the probe using side fire 
crystal,  then  we  switched  over  to  end  firing  crystal  we  took 
midline sagittal section and then by rotating the probe towards 
right and left we took right and left paramedian sections.
MRI Technique used:
Patient was placed in supine position in the MR gantry.
A  scout  sagittal  section  was  obtained  through  the  prostate  for 
planning of coronal and axial views.
Sections were taken extending from base to the apex of the prostate 
including the seminal vesicles.
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The sequences used were,
a) T2 weighted sequence.
TR: 4000 ms TE - 101 ms
Averages: 2 No of slices: 12-15
Slice thickness: 5mm FOV - 200 mm
Axial, Sagittal, Coronal oblique.
b) Short Tau inversion recovery sequence (STIR)
TR: 2300 ms TE - 20 ms TI: 150 ms
Averages: 2 No of slices: 12-15
Slice thickness: 3mm FOV - 200 mm
Axial, Sagittal, Coronal oblique.
c) Optional Sequences
a) T1 weighted sequence
Inclusion Criteria:
All  the patients in the study were referred from Urology Department 
with  symptoms  of  prostatic  enlargement  like  frequency,  urgency,  urge 
incontinence  and  hesitancy.   Broadly  the  patients  included  fall  into  the 
following criteria.
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i. Diffusely enlarged prostate as per DRE
ii. Patients with hard prostatic nodule.
iii. Patients having tender enlarged prostate.
iv. To evaluate those patient with osteoblastic bone secondaries.
Exclusion Criteria:
Patients not willing to undergo TRUS &MR Examination
Patients with MR incompatible devices/implants
Those patients who are unable to lie down in supine/lateral position.
Patients with claustrophobia.
Those patients who are not operated or non availability of HPE report
Biopsy criteria:
Patients showing features of BPH were subjected for Trans- urethral 
resection of prostate and specimen sent for HPE.
Patients showing inhomogenous echotexture of prostate and nodular 
lesion irrespective of their zonal distribution were subjected for usg guided 
biopsy of prostate through transrectal route. 
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TRUS guided Biopsy Technique
We used the same convex transrectal probe with biopsy gun holder 
attached  to  it  which  was  wrapped  in  a  sheath  .To  ensure  good  acoustic 
contact  USG gel   was  put  inside  the  sheath.  Bard’s  18  gauge automatic 
spring loaded biopsy gun was used for taking biopsy.
Pre biopsy instruction were followed in all patient which included
Clotting parameters, Bowel cleaning enema.
Withdrawal  of  anticoagulants for 1 week if  the patient is on anticoagulant  
therapy.
Antibiotic prophylaxis:  (1).Tab Taxim 0-250mg tds 5 days -  2 days prior.  
(2) .Tab. Metrogyl 400mg 1 hour before.
After  putting  the  patient  in  left  lateral  position,  Digital  rectal 
examination was done, to confirm the prostatic enlargement and to localize 
the nodular  lesions.  Then rectal  probe with  biopsy gun holder  was slowly 
introduced. Scan was done in both planes from base to apex and from side 
to  side  also  necessary  images  were  recorded.   Echotexture,  nodules, 
calcification were noted. Evaluation of capsule, SV & ED was done. Colour  
Doppler was used to know vascularity of the lesion and biopsy was taken in 
a systematic way from 6 sites (2 each from base, mid gland & apex) and 
also from suspicious lesions.
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After observing for any post-procedural complications, rectal probe was 
taken out, post procedure analgesic and antibiotics were also given.
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REPRESENTATIVE CASES
NORMAL PROSTATE
Fig 1: TRUS -AXIAL
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Fig 2: T-2 AXIAL
BENIGN PROSTATIC   HYPERPLASIA [BPH]
Fig 3: TRUS -AXIAL
Fig 4: STIR- AXIAL
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A &  C –  Femoral 
Head
B - Bladder
E - Rectum
D - Prostate
Fig 5: T-2   CORONAL 
CARCINOMA PROSTATE
Fig 6: TRUS – AXIAL
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Fig 7: TRUS- SAGITTAL
CARCINOMA PROSTATE
 
Fig 8: STIR - AXIAL
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         Fig 9: T-2 CORONAL         Fig 10: T-2 
SAGITTAL
PROSTATITIS / ABCESS
Fig 11: TRUS-AXIAL
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Fig 12: T-2 CORONAL  
CARCINOMA PROSTATE WITH RT FEMORAL AND ILLIAC BONE 
METASTASIS
Fig 13: T2 – AXIAL
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DEGENERATIVE PROSTATIC CYST
Fig 14: TRUS AXIAL 
BIOPSY GUN AND ITS HOLDER ATTACHED TO TRANSRECTAL PROBE
Fig 15:
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TRUS AXIAL SECTION WITH BIOPSY NEEDLE INSITU
Fig 16:
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NODULAR BPH
Fig 17: TRUS AXIAL
NODULAR BPH
Fig 18: T2 WI AXIAL
BOTH SEMINAL VESICLE AND AMPULLA OF VAS DEFERENS
Fig 19: TRUS AXIAL
CA PROSTATE SHOWING INCREASED VASCULARITY
Fig 20: COLOR DOPPLER
RESULTS AND ANALYSIS
Our  study  included  those  patients  having  prostatic  problems  or 
palpable  nodules  in  the  prostate  detected  by  digital  rectal  examination. 
They were between age groups 44-78 years.
We  examined  50  patients  by  transrectal  sonography  with  colour 
Doppler and MR examination.
All  patients  were  classified  depending  on  the  sonographic 
appearance of prostate into various groups as follows 
Group - 1: Enlarged  prostate  showing  homogenous 
echotexture 28/50
Group - 2: Enlarged  prostate  showing  inhomogenous 
echotexture 7/50.
Group - 3: Prostate showing nodular lesions 8/50
Group - 4: Tender enlarged mixed echogenic prostate 
with cystic areas 5/50.
Group - 5: Prostate  showing  echolucent  cystic  lesions 
without  septations 2/50.
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TRANSRECTAL SONOGRAPHIC FEATURES
28
7
8
5
2
Group1
Group2
Group3
Group4
Group5
All Group 1 patients were assigned as benign prostatic enlargement 
and  were  sent  for  transurethral  resection  of  prostate.  No  histopathologic 
results were reported as malignancy.
All Group 2 and Group 3 patients were subjected for guided biopsy of  
prostate. 15 were subjected for guided biopsy of which 6 results came as 
malignancy 4 as benign and 5 turned to be negative biopsy (Inconclusive).
All  Group  4  patients  were  treated  with  a  course  of  antibiotics  and 
they  were  re-examined  with  transrectal  sonography.  Repeat  examination 
shows reduction in the size of lesions in 4 patients, and 1 patient did not  
show any size reduction  and he was  subjected for  biopsy.  Biopsy turned 
out to be malignant.
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            All group 5 patients are assigned as cases of prostatic cyst and no 
treatment offered for them.
By ultrasonographic examination we assigned 28 patients as cases 
of  BPH.  Biopsy  results  of  2  nodular  lesions  and  2  prostate  showing 
inhomogenous echoes turned out to be benign.
Out of  8 nodular  lesions 4 presented as hypoechoic nodules in the 
peripheral  zone.  Two  lesions  were  isoechoic  nodules  with  diffuse 
involvement  of  prostate  with  loss  of  normal  zonal  anatomy  and  surface 
irregularity, and 2 other lesions were hyperechoic nodule in transition zone.  
Of  these  lesions  we  suspected  6  as  malignancy  because  of  surface 
irregularity  and  because  they  were  in  the  peripheral  zone,  2  lesions  as 
inconclusive, of which 5 tuned out to be malignant, and 2 as benign. One 
biopsy from group 4 turned out as malignant.
The  ability  of  TRUS  to  localise  &to  diagnose  various  benign  and 
malignant lesions depending on their sonographic features were compared 
with HPE results using various statistical tests.
McNemar’s and Chi square test were used to evaluate whether there 
is any significant difference between TRUS and HPE results.
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                                               TRUS Vs. HPE 
Malignant Benign
Malignant 6 2
Benign 1 36
Estimate
95% CI
(Confidence 
interval)
Sensitivity 85.7 42.1-99.6
Specificity 94.7 82.3-99.3
Correct  classification 
rate
93.3 81.7-98.6
Missed classification rate 6.7 1.4-15.5
Positive predictive value 75 35-97
Negative  predictive 
value
97 86-99
False positive rate 5.2 0.0-18
False negative rate 14.2 0.0-57
Kappa agreement 0.76 0.5-1
Likelihood ratio + 16.3 4.1-64.1
Likelihood ratio – 0.15 0.03-0.93
McNemar’s test χ2= 0.33 P = 1.00
(Not significant)
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MRI RESULTS
Taking  nodular  hypointense  lesion  in  peripheral  zone,  with  or  without 
capsular breech as MR features suggesting malignancy, out of 8 patient 5 
were assigned as malignant.    More over MR picked up one patient with  
capsular breech which was not seen in TRUS.
    Group I  patients showed enlarged gland with  mixed intense transition 
zone  with  normal  hyperintense  peripheral  zone.   In  Group  II  patients 
enlarged gland with mixed intense signal were noted in transition & central  
zone. But no e/o capsular breech and surface irregularity were seen. Hyper 
intense peripheral zone also appeared normal.
            In Group IV patient, MR showed mixed intense lesion in T 2 WI with 
irregular walls involving diffusely.
 In Group V patients MR showed well defined hyperintense lesion in 
the centre of gland with normal peripheral areas.
In  group  III  patients  5  of  8  patients  showed  hypointense  nodular 
lesions involving the peripheral  zone. 3 of  which showed capsular breech 
and 1 patient also showed adjacent femoral & iliac bone involvement and of 
the  other  3  in  2  patients  mixed  intense  nodular  lesions  were  noted  in  
central gland and in 1 patient no nodule was detected in MR.
The ability of MRI to detect the various benign and malignant lesions 
depending on their signal characteristics were compared with HPE results  
49
using various statistical tests. McNemar’s and Chi square test were used to 
evaluate whether there is any significant difference between MRI and HPE 
results.
Estimate 95% (Confidence interval)
Sensitivity 71.4 29-96
Specificity 100 91-100
Correct classification rate 96 85-99
Missed classification rate 4 1-20
Positive predictive value 100 48-100
Negative predictive value 95 83-99
False positive rate 0 0-9
False negative rate 29 4-71%
Kappa agreement 0.81 0.55-1
Likelihood ratio + NA
Likelihood ratio – 0.29 0.9-0.99
McNemar’s test χ2= 2.01 P = 0.48
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Malignant Benign
Malignant 5 –
Benign 2 38
    SENSTITIVITY AND SPECIFICITY GRAPH OF MRI AND TRUS Vs HPE
                  MRI Vs HPE
                TRUS Vs HPE
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AGE DISTRIBUTION
Age No. of Respondents Percentage
40-45 years 3 6%
46-50 years 1 2%
51-55 years 6 12%
56-60 years 16 32%
61-65 years 8 16%
66-70 years 6 12%
71-75 years 7 14%
76-80 years 3 6%
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PRESENTING COMPLAINTS
Complaint No. of Respondents Percentage
Nocturia 25 50%
Hesitancy 19 38%
Acute Retention 13 26%
Poor Stream 10 20%
Urgency 9 18%
Hematuria 4 8%
Most of our patients presented with more than one complaint.
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CASE DISTRIBUTION
Case No. of Respondents Percentage
BPH 32 64%
Ca Prostate 7 14%
Abscess 4 8%
Cyst 2 4%
Inconclusive 5 5%
Most of our patients presented with more than one complaint.
CASE DISTRIBUTION
BPH
64%
Ca Prostate
14%
Abscess
8%
Cyst
4%
Inconclusive
10%
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Weighted  Kohen’s  Kappa is  calculated  by  observed  frequency  of 
agreement minus expected frequency of agreement divided by total 
observed minus expected frequency of agreement.
Mc Nemar’s  test – It is a variant of the  Chi Square test, used only 
when  both  the  independent  and  dependant  variables  are 
dichotomous.
Weighted Kohen’s Kappa for TRUS with HPE correlation is 0.76 with  
intra class correlation coefficient ranging from 0.5 – 1
Similarly  weighted  Kohen’s  Kappa  for  MRI  with  HPE correlation  is 
0.81 with intra class correlation coefficient ranging 0.55 to 1.
Values of Kappa were classified as bad (less than 0.4) good (0.4 to 
0.75)  or  excellent  (greater  than  0.75)  following  Landis  and  Koch’s 
criteria.
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 DISCUSSION
Although  prostate  cannot  be  directly  visualized  by  conventional 
methods,  Intravenous  urography  and  cystourethrography  can  show  the 
prostatic impression in the floor of the urinary bladder. The urethra may be 
elongated and it  appears compressed, looking like a slit  on    A.P. View.  
During ascending urethrogram or voiding cysto-urethrogram it may produce 
a  smooth  filling  defect  in  the  floor  of  the  bladder.  At  times  intra-vesicle  
filling  defect  may  be  produced  by  enlargement  of  the  periurethral  and 
subvesicular  part.  I.V.U.  may shows  J-Shaped  (fishhook  deformity)  distal  
ureters due to enlarged prostate pushing the bladder trigone upwards.
Early prostatic cancers cannot be picked up by conventional contrast 
studies or by transabdominal ultra sonography of the prostate. However in  
late  stages  when  the  prostatic  carcinoma  extends  towards  the  urethra, 
irregular  Contour  of  prostatic  urethra  and  bladder  base  can  be  seen  in  
voiding cystourethrography.
If  seminal  vesiculogram  is  performed  the  medial  portion  of  the 
seminal  vesicle  are  seen  to  be  decrease  in  size,  related  to  tumour  
infiltration  and  lateral  portion  of  seminal  vesicle  may  be  dilated.  The 
junction between the ductus deferens and the lateral part of seminal vesicle 
may also be dilated, and the junction between the ductus deferens and the 
ejaculatory duct may be depressed. Contrast medium may have a greater  
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tendency to  flow distally  rather  than back into  the bladder  when entering 
the posterior urethra from the ejaculatory duct.
On  transabdominal  ultrasonography  prostate  appears  as  a 
homogenous,  round  to  slightly  ovoid  structure,  with  uniform,  low  level  
echoes.  The  relationship  between  the  bladder  and  the  prostate  can  be 
demonstrated.  But  the  normal  zonal  anatomy  of  the  prostate  cannot  be 
demonstrated. Early hypo echoic cancers in the peripheral zones cannot be 
picked up.  The prostate and periprostatic  tissue are well  visualized using  
computed tomography. But neither the zonal anatomy nor the differentiation 
between  the  prostatic  parenchyma  and  the  prostatic  capsule  were 
visualised.
On magnetic resonance imaging the ability to demonstrate the zonal 
anatomy  of  the  prostate  and  the  distinction  between  the  gland  and 
periprostatic tissue varies with the imaging plane and sequences used .On 
spin  echo  T1  WI,  regardless  of  field  strength,  the  prostate  shows   a 
homogenous  signal  of  intermediate  intensity  and  the  zones  cannot  be 
differentiated .On T2 WI the zonal anatomy is well delineated with prostatic 
urethra  as  a  key  point  .Endorectal  coil  MRI  is  the  imaging  modality  of  
choice at present for detecting and accurate staging of prostate cancer but 
it is much costlier and is not available in all places. 
Robert L.Bree et al.,22 described that the  sonographic appearance 
of  BPH is  varied  and  depends  on  the  histopathological  changes.  Diffuse 
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enlargement of the transition zone with homogenous echoes will be seen in 
fibromuscular  hyperplasia,  inhomogenous  echoes,  in  cases  showing 
combination  of  fibromuscular  and  adenomatous  element,  hyperechoic 
nodules in cases of prostatic adenoma.
In  our  series  out  of  32  cases  of  BPH,  28  patients[87%]  showed 
diffuse homogenous hypoechogenicity of transition zone, 2 patients [6.25%] 
showed  hyperechoic  nodules  in  the  transition  zone.  1  patient  [3.1%] 
showed inhomogenous echotexture of transition zone. 
Mathew D.  Rifkin  et  al9 reported  presence  of  smooth  and  regular 
capsule as a sign of benign lesion. In his series 93% cases of BPH had a 
smooth capsule. In our series all 32 cases [100%] of BPH had smooth and 
intact capsule.
R.Malik et al37 in his study showed sensitivity &specificity of TRUS to 
diagnose  carcinoma  prostate  to  be  87%and72%  respectively,  our  study 
showed a  sensitivity  of  86% and  specificity  of  90%.
Fred Lee et al6 in his series reported 8 hyperechoic nodules of which 
7 were proved to be BPH by histopathology. In our series we came across 
2  hyperechoic  nodules  and both  turned out  to  be  benign lesions.  So our 
results are closely matching with his results.
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The mean age of patients with prostatic cancer was 69yrs in    Fred 
Lee  et  al6 studies.  In  our  study  the  mean  age  of  patients  with  prostatic 
cancer is 66.5yrs.
Katsuto  Shinohara  et  al7 in  their  series  reported  67% of  cancers 
presenting  as  hypoechoic  lesions,  32%  as  isoechoic  lesions  and  1%  as 
hyperechoic  lesions.  In  our  studies  5  of  the  7  malignant  lesions  were 
hypoechoic forming 71% and 2 of 7 were seen as isoechoic lesions forming 
29%. We have not come across hyperechoic malignancy in our study.
Most  of  the  study materials  showed 70% of  carcinomas arise  from 
peripheral  zones,  20% in  transition  zone and l0% in  central  zone.  In  our 
study out of 7 malignant lesions 4 were seen in peripheral zone (57%), 1 in  
transition zone (15%) and 2 cases were diffuse (38%). This disparity may 
be because of small representative volume.
A tumour occupying most of the prostate may not be visible on ultra 
sonography.  This  is  called  superscan  phenomenon,  where  a  tumour 
virtually replaces the entire prostate so that there is little normal tissue for  
comparison, as a result the gland has uniform echo pattern and the cancer 
is  not  appreciated.  Salo  et  al.  reported  that  poorly  differentiated  tumour 
diffusely involving the prostate often appear as mixed echoic or isoechoic.  
In  our  study  2  cases  of  malignant  lesions  were  diffusely  involving  the 
prostate causing obscuration of normal zonal anatomy of prostate and they 
were seen as isoechoic. This is because of superscan phenomenon.
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Katsuto  Shinohara  et  al7 reported  that  obviously  irregular 
asymmetric  gland  often  signals  malignancy  even  in  the  absence  of  an 
identifiable  hypoechic  lesion.  In  our  study  we  identified  2  isoechoic 
malignancy mainly because of the surface irregularity of prostate.
Peter  T.  Scardino  et  al8 said  hyperechoic  tumours  are  rare.  They 
explained that they are ductal carcinomas with comedo type tumour nests 
containing  calcifications  and  necrotic  debris  causing  multiple  acoustic 
interfaces  to  give  a  hyperechoic  appearance.  In  our  study  we  have  not 
come across hyperechoic malignancy.
Katsuto  Shinohara  et  al7 in  their  series  detected  67  cancers  by 
sonography and all  67 were palpable by digital  rectal  examination.  In our 
study out of 7 cancers 6 were palpable lesions.
Kathryn  K.  Hodge and  John  E.  McNeal  et  al16 in  their  series 
reported that out of 136 patients subjected for biopsy 86 were positive for  
cancer (61%). The mean number of biopsy per patient was 7. In our study 
out  of  15  prostatic  biopsy we  have  come across  7  malignancies  forming 
46%. The mean number of biopsy per patient is 1.
Andrew  Doble and  Simon  St.  C.  Carter  et  al19 formulated 
ultrasound signs in inflammatory prostatic diseases. They are as follows,
• Hyperdense echoes
• Midrange echoes
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• Echolucent zones
• Ejaculatory duct calcification
• Capsular thickening
• Periurethral zone irregularity
We  have  come  across  5  lesions  showing  hypoechogenicity  with 
midrange echoes out  of  which  4 were  abscesses and 1 turned out  to  be 
malignant. (Probably because of necrosis of tumour).
.According  to  Bezzi  M  et  al23 majority  of  the  prostatic  malignant 
lesion  shows  hypointensity  in  T2WI.  In  our  study also  out  of  7  malignant 
lesion 6 were (85%) of lesion were hypointense in T2WI.
Studies done by Yu et al28 and McNeal JE et al16 shows that MR is 
more  sensitive  than  TRUS  in  detection  of  Transcapsular  extension  and 
spread. In our study also 2 cases of transcapsular extension was detected 
by  MR  where  TRUS  detected  only  1  case  and  thus  the  staging  was 
changed from stage 2  to stage 3.
Experience  with  MRI  of  prostatitis  and  abscess  is  limited  and 
reported  findings  differ.  Some  investigators  report  on  Inhomogenous 
appearance of the gland in c/c prostatitis with signal intensity similar to that  
of normal prostate. Other report that both a/c and c/c prostatitis may show 
multiple small  areas of increased signal intensity scattered throughout the 
61
prostate on SE-T2WI. In our study also enlarged prostate with heterogenous 
signal intensity were noted.
Studies done by Shigeno K et al31 (BJU-2000) shows the use of CDI 
when used along with TRUS where hyper vascular malignant lesion, could 
be  located more  accurately  and it  increases  the  sensitivity  and negative 
predictive value in detecting carcinoma prostate. Inflammatory lesions also 
show increased vascularity.
In  our  study  out  of  seven  malignant  lesions  5  showed  increased 
vascularity and four benign lesions also showed increase vascularity, which 
proved to be of inflammatory cause. 
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SUMMARY 
TRUS with  colour  Doppler  and  MRI  were  performed in  50  patients 
referred  from the department  of  Urology.  Patients  belonged to  age group 
41-78 years. The results were compared with the histopathological results 
obtained by TRUS guided biopsy and TURP specimen.
A  majority  of  the  patients  (64%)  were  having  generalised 
enlargement  of  prostate  with  main  symptoms  as  nocturia  (50%)  and 
Hesitancy (38%).
Taking Inhomogenous echoes and hypoechoic nodular lesions in PZ 
with  surface  irregularity  as  sign  of  malignancy  TRUS  proved  to  be  very 
sensitive in detecting malignant lesion. Sensitivity (85.7%).
   By MRI the extent and invasion of prostate cancer into periprostatic  
tissues were better delineated. Also taking a hypointense lesion in the PZ 
in T2 WI as sign of malignancy, MRI showed sensitivity of 71.4%.
However  in  our  study,  Nodular  lesions  detected  by  TRUS  were 
missed by  MRI.   It  may be due to  the  decreased resolution  of  Body coil  
MRI.
A weighted Cohen’s kappa coefficient measure of TRUS was found 
to be 0.64 and for MRI it was 0.77. Values of Kappa were classified as bad  
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(less than 0.4), Good (0.4 - 0.75) or excellent (greater than 0.75), following 
Landis and Koch’s criteria.
Similarly,  intra  class  correlation  coefficient  with  95%  confidence 
interval for TRUS were found to be 0.36 - 0.93 and for MRI was 0.48 - 1.00.  
Value  of  intra  class  correlation  coefficient  which  are  nearer  to  1.00, 
indicates an excellent correlation.
Using Doppler it was able to localise better the vascular lesions. But 
both malignant and inflammatory lesions show increased vascularity.
TRUS is also an excellent modality to do guided Biopsy and helps to 
increase the yield of procedure comparing to the blind biopsy technique.
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CONCLUSION
Transrectal  sonography is a good modality to characterize prostatic 
lesions as benign and malignant.
Hypoechoic  lesion  distributed  in  peripheral  zones  with  surface 
irregularity is a reliable sign of malignancy.
Increased  AP  dimension  causing  more  rounded  configuration  of 
prostate with smooth capsule is a good sign of benignity
It  is  a  good modality  to  identify  local  spread of  malignancy.  It  is  a 
good guiding system for prostatic biopsies 
It is minimally invasive and easy to perform.
It  is  safe,  no  radiation  hazard,  comparatively  cheap  and  can  be 
repeated for any number of times.
MRI  is  also  a  good  modality  to  localise  the  lesion  in  prostatic  
carcinoma. It is better than TRUS in determining the extent of the disease.
MRI also gives the surgeon a three dimensional picture of the lesion 
and prostate before surgery so that he is able to plan better.
MRI  helps  us  to  know  the  involvement  of  other  organ  and  lymph 
nodes in case of metastatic disease.
MRI is also safe without any radiation hazard. 
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TRUS  appeared  to  be  more  sensitive  than  MRI  in  detecting  the 
lesions, maybe because of body coil we used in MR examination
Even  with  body  coil  MRI  we  are  able  to  localise  the  lesion  and 
extension  of  the  disease  to  greater  extent  with  additional  advantage  of 
larger FOV compared to Endorectal MRI.
In colour Doppler increased vascularity is seen in both malignant and 
inflammatory lesions, and it  helps to accurately localize the lesions, while 
performing biopsies.
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ANNEXURE
ABBREVIATION
TRUS Transrectal ultrasonogram
MRI Magnetic Resonance Imaging
CT Computed Tomography
CDI Colour Doppler Imaging
BPH Benign Prostatatic Hyperplasia
CZ Central Zone
PZ Peripheral Zone
TZ Transitional Zone
A/c Acute
C/C Chronic
WI Weighted images
NVB Neuro vascular bundles
TR Relaxation Time
TE Echo time
STIR Short Tau Inversion Recovery
3D MRSI Three Dimensional Magnetic Resonance 
Spectroscopic Imaging
FOV Field of view
MHz Megahertz
HPE Histopathological Examination 
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PROFORMA
SL. NO: NAME: AGE:      
IP. NO:
Presenting complaint:
Past History:
Vital signs:
General Examination:
Digital Rectal Examination:
Investigations:
1. PSA:
2. Trans abdominal USG:
73
3. Trans Rectal USG :
     Volume:
    Site of lesion:
    Echogenecity: 
Gland Asymmetry: 
 
4. Colour Doppler:
5.    MRI :
6.  TRUS guided biopsy:
7.   Summary:
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SL
.N
o.
NAME A
ge Clinical 
history DRE TRUS MRI Doppler Biopsy
1 Muthukumar 62 poor stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity
BPH TURP-
no 
malignancy
2 Madasamy 57 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity BPH 
3 Sakthivel 53
nocturia, 
hematuria
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
Inhomogenous echos,Cz 
Pz-normal 
Enlarged mixed intense Tz 
in T2WI with normal 
hyperintense Pz
peripheral 
vascularity negative
4 Elumalai 60 A/C retention
Enlarged 
tender 
prostate
enlarged mixed echogenic 
prostate with hypoechoic 
areas on rt side with 
internal echos treated with 
antibiotics pain subsided 
(PROSTATITIS)
Enlarged prostate with 
illdefined hyperintense 
lesion in Tz measuring1.2 * 
1.1 cm
increased 
vascularity
prostatitis/ab
scess
5 Kumar 58 Nocturia 
Enlarged 
prostate
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity BPH
6 Ezhilan 78
hematuria 
,poor stream
multiple 
hard 
nodules
Enlarged prostate with 
surface irregularity, zonal 
anatomy lost
Enlarged prostate with loss 
of hyperintensity in Pz in 
T2WI with capsular breech, 
no e/o seminal vesicle 
involvement
diffusely 
increased 
vasculrity
carcinoma 
prostate
7 Rajkumar 73 Nocturia
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity BPH
8 Ramalingam 61 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity BPH
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SL
.N
o.
NAME A
ge Clinical 
history DRE TRUS MRI Doppler Biopsy
9 Karthikeyan 58
hesitancy 
poor stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal 
vascularity BPH
10
Thangasam
y
71 Nocturia poor stream 
hard 
nodule in 
mid line 
nodular hypopechoic lesion 
measuring 1cx1.3cm seen 
in pz in mid line, capsule 
intact SV -normal 
hypointense nodular lesion 
seen involving the Tz 
,capsule intact ,SV - N
normal carcinoma prostate
11  Irulandi 72
Nocturia, A/C 
retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
12
Mohammed 
abbas
75 Nocturia, A/C retention
hard 
nodule RT 
side
Irregular hypoechoic lesion 
measuring 1.4x1.2cm in the 
rt lobe
ill defined hypointense 
lesion in T2 WI seen in Pz 
on rt side .no e/o capsular 
breech /seminal vesicle 
invasion 
the lesion 
shows 
increased 
vascularity
carcinoma 
prostate
13 Karuppaiah 68 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
 Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
14 Nazar 74 poor stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
15 Manickam 69
nocturia, 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
Inhomogenous echos,Cz 
Pz-normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal negative
16 Subbair 77
nocturia, 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
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17 Manikam 48 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
18 Selvam 74 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
19 Subramani 64
hesitancy 
poor stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
20 Raman 63 Nocturia
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
mixed intense enlarged Tz 
with normal hyperintense 
Pz
normal BPH
21 Chinnappa 67 nocturia
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
Inhomogenous echos,Cz 
Pz-normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal Negative
22 Raju 41
pain in the 
perineum, 
retention 
enlarged 
tender 
prostate 
Enlarged mixed echogenic 
left lobe displacing the 
folleys catheter to the rt, 
Repeat USG after antibiotic 
course shows reduction in 
size of lesion s/o a/c 
prostatitis.
enlarged mixed intense 
prostate involvivg left lobe 
with folleys Insitu
diffusely 
increased 
vasculrity
prostatitis/ab
scess
23 Ramar 51 Nocturia
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
24 Velan 42 hesitancy 
Enlarged 
prostate, 
No nodules
well defined cystic lesion 
measuring 1.2x1.1cm seen 
on rt side in T2 WITH 
acoustic enhancement
well defined hyperintense 
lesion in T2WI Avascular
prostatic 
cyst
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25 Hariharan 60
Nocturia, 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
26 Chinnasamy 62
hesitancy, 
hematuria
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
27 Chelladurai 57
nocturia, poor 
stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Mixed intense enlarged Tz 
with normal hyperintense 
pz
normal BPH
28 Muthu 67 hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
29 Ponnaiah 59
hesitancy, 
nocturia
hard 
nodule on 
rt side
irregular hypoechoic lesion 
measuring 1.5x1.1cm in the 
rt lobe, seen invading sv 
with capsular breech
hypointense lesion in Rt Pz 
with focal bulge and 
capsular breech and sv 
involvment seen in T2WI. 
Also there is e/o femoral 
and illiac bone involvement
increased 
vascularity 
seen in the 
hypoechoic 
lrsion
carcinoma 
prostate
30 Alagappan 55
Nocturia. a/c 
retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
31 Lingappan 46 urgency
smooth 
enlarged 
prostate 
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal
BPH TURP-
no 
malignancy
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32 Pitchai 44 A/C retention
firm nodule 
on rt side
prostate more rounded in 
configuration hyperechoic 
nodule measuring 
1.7x1.7cm seen in rt tz 
causing compression of 
urethra CZ&PZ--normal
Enlarged Tz with an mixed 
intense lesion measuring 
1.6x1.5 cm Cz &Pz--N
normal
BPH TURP-
no 
malignancy
33 Ismail 69 Hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
34 Sami 45
Nocturia , 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
35 Ramasamy 65
Nocturia. a/c 
retention
multiple 
hard 
nodules
enlarged prostate with 
surface bulge , zonal 
anatomy lost
enlarged prostate with 
hypointense lesion seen 
involving both peripheral & 
central zone without 
capsular breech
diffusely 
increased 
vasculrity
carcinoma 
prostate
36 Karuppiah 59 A/C retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
37 Muthiah 64
urgency , 
hesitancy
enlarged 
prostate 
,no nodule
enlarged heterogenous 
central gland with 
hypoechoic nodular lesion 
noted in left side Pz
shows mixed intense 
enlarged central gland , no 
lesion was detected in Pz
increased 
vascularity
carcinoma 
prostate
38 Mani 76
Nocturia , 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
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39 Muthu 50
Nocturia, 
Pain in 
perineum
Tender 
enlarged 
prostate
Ill defined hypoechoic 
lesion with internal 
septations seen on left side 
in TZ measuring 1.5x1.5 
cm, repeat sonogram 
shows reduction in size of 
the lesion
Enlarged prostate with ill 
defined hyperintense 
lesions in TZ measuring 1.2 
x 1.1 cm
diffusely 
increased 
vasculrity
Abscess / 
Prostatitis
40 Shankar 64 Hestancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
Inhomogenous echos,Cz 
Pz-normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal Negative
41 Munnian 54
Hesitancy & 
hematuria
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
42 Vellaichamy 60
nocturia,poor 
strem ,pain in 
the perineum
enlarged 
tender 
prostate 
,no nodules
well defined hypoechoic 
lesion with echogenic wall 
& internal echoes seen on 
rt side in TZ ,treated with 
antibiotics ,rpt usg revealed 
same findings
mixed intense well defined 
lesion seen in the Tz in rt 
side it is predominantly 
hyper intense in T2WI
normal Carcinoma prostate 
43
Thulasirama
n
67 Nocturia. a/c retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
44 Ramadoss 60
Nocturia , 
hesitancy
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
Inhomogenous echos,Cz 
Pz-normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal Negative
45 Sreeni 52
hesitancy, a/c 
retention
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
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46
Kulanthaisa
my
60 nocturia, poor stream
Enlarged 
prostate, 
No nodules
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
47 Thoogapillai 60 poor stream
Enlarged 
prostate, 
No nodules
a well defined cystic lesion 
seen measuring 1.5 x1.2cm 
in Tz in midline with 
acoustic enhancement
well defined hyperintense 
lesion in T2WI in Tzin the 
midline
Avascular prostatic cyst
48 Alladeep 58
Nocturia, 
hesitancy
firm nodule 
on lt side
Round hyperechoic nodule 
measuring 1.2 x1.2 cm 
seen in lt side of Tz
hyperintense lesion seen in 
the enlarged Tz on lt 
side .Pz normal
normal BPH
  49 Subramani 36
painful 
micturition 
with pyuria
tender 
prostate
e/o ill defined hypoechoic 
lesion seen in the rt lobe 
involving central gland ,Rpt 
usg after antibiotics shows 
reduction in size 
Enlarged prostate with a 
hyperintense lesion in the rt 
lobe in T2 WI , no e/o 
surface irregularity/ 
capsular breech 
normal prostitis/ abscess
  50 Subbaiah 57 hesitancy
smooth 
enlarged 
prostate 
Tz hypertrophied, 
homogenous echos,Cz Pz-
normal 
Enlarged mixed intense TZ 
with hyper intense PZ normal BPH
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KEY TO MASTER CHART
SB No Serial Number
TZ Transitional Zone
PZ Peripheral Zone
CZ Central Zone
DRE Digital Rectal Examination
TRUS Trans rectal  Ultra Sonogram
MRI Magnetic Resonance Imaging
BPH Benign Prostatic Hyperplasia
TURP Transurethral Resection of prostate  
SV Seminal vesicle
ED Ejaculatory Duct
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